208 related articles for article (PubMed ID: 21183956)
1. SUMO-specific protease 2 in Mdm2-mediated regulation of p53.
Jiang M; Chiu SY; Hsu W
Cell Death Differ; 2011 Jun; 18(6):1005-15. PubMed ID: 21183956
[TBL] [Abstract][Full Text] [Related]
2. SUMO-specific protease 2 is essential for modulating p53-Mdm2 in development of trophoblast stem cell niches and lineages.
Chiu SY; Asai N; Costantini F; Hsu W
PLoS Biol; 2008 Dec; 6(12):e310. PubMed ID: 19090619
[TBL] [Abstract][Full Text] [Related]
3. Extraembryonic but not embryonic SUMO-specific protease 2 is required for heart development.
Maruyama EO; Lin H; Chiu SY; Yu HM; Porter GA; Hsu W
Sci Rep; 2016 Feb; 6():20999. PubMed ID: 26883797
[TBL] [Abstract][Full Text] [Related]
4. The nucleolar SUMO-specific protease SMT3IP1/SENP3 attenuates Mdm2-mediated p53 ubiquitination and degradation.
Nishida T; Yamada Y
Biochem Biophys Res Commun; 2011 Mar; 406(2):285-91. PubMed ID: 21316347
[TBL] [Abstract][Full Text] [Related]
5. Enhanced desumoylation in murine hearts by overexpressed SENP2 leads to congenital heart defects and cardiac dysfunction.
Kim EY; Chen L; Ma Y; Yu W; Chang J; Moskowitz IP; Wang J
J Mol Cell Cardiol; 2012 Mar; 52(3):638-49. PubMed ID: 22155005
[TBL] [Abstract][Full Text] [Related]
6. SUMO regulates p21Cip1 intracellular distribution and with p21Cip1 facilitates multiprotein complex formation in the nucleolus upon DNA damage.
Brun S; Abella N; Berciano MT; Tapia O; Jaumot M; Freire R; Lafarga M; Agell N
PLoS One; 2017; 12(6):e0178925. PubMed ID: 28582471
[TBL] [Abstract][Full Text] [Related]
7. SUMO-specific protease SUSP4 positively regulates p53 by promoting Mdm2 self-ubiquitination.
Lee MH; Lee SW; Lee EJ; Choi SJ; Chung SS; Lee JI; Cho JM; Seol JH; Baek SH; Kim KI; Chiba T; Tanaka K; Bang OS; Chung CH
Nat Cell Biol; 2006 Dec; 8(12):1424-31. PubMed ID: 17086174
[TBL] [Abstract][Full Text] [Related]
8. The requirement of SUMO2/3 for SENP2 mediated extraembryonic and embryonic development.
Yu HI; Hsu T; Maruyama EO; Paschen W; Yang W; Hsu W
Dev Dyn; 2020 Feb; 249(2):237-244. PubMed ID: 31625212
[TBL] [Abstract][Full Text] [Related]
9. De-SUMOylation enzyme of sentrin/SUMO-specific protease 2 regulates disturbed flow-induced SUMOylation of ERK5 and p53 that leads to endothelial dysfunction and atherosclerosis.
Heo KS; Chang E; Le NT; Cushman H; Yeh ET; Fujiwara K; Abe J
Circ Res; 2013 Mar; 112(6):911-23. PubMed ID: 23381569
[TBL] [Abstract][Full Text] [Related]
10. Disruption of SUMO-specific protease 2 induces mitochondria mediated neurodegeneration.
Fu J; Yu HM; Chiu SY; Mirando AJ; Maruyama EO; Cheng JG; Hsu W
PLoS Genet; 2014 Oct; 10(10):e1004579. PubMed ID: 25299344
[TBL] [Abstract][Full Text] [Related]
11. SUMO-specific protease 2-mediated deSUMOylation is required for NDRG2 stabilization in gastric cancer cells.
Hu XY; Liu Z; Zhang KL; Feng J; Liu XF; Wang LY; Wang ZW
Cancer Biomark; 2017 Dec; 21(1):195-201. PubMed ID: 29060933
[TBL] [Abstract][Full Text] [Related]
12. CRMP2 protein SUMOylation modulates NaV1.7 channel trafficking.
Dustrude ET; Wilson SM; Ju W; Xiao Y; Khanna R
J Biol Chem; 2013 Aug; 288(34):24316-31. PubMed ID: 23836888
[TBL] [Abstract][Full Text] [Related]
13. MDM2 promotes SUMO-2/3 modification of p53 to modulate transcriptional activity.
Stindt MH; Carter S; Vigneron AM; Ryan KM; Vousden KH
Cell Cycle; 2011 Sep; 10(18):3176-88. PubMed ID: 21900752
[TBL] [Abstract][Full Text] [Related]
14. The RanBP2/RanGAP1-SUMO complex gates β-arrestin2 nuclear entry to regulate the Mdm2-p53 signaling axis.
Blondel-Tepaz E; Leverve M; Sokrat B; Paradis JS; Kosic M; Saha K; Auffray C; Lima-Fernandes E; Zamborlini A; Poupon A; Gaboury L; Findlay J; Baillie GS; Enslen H; Bouvier M; Angers S; Marullo S; Scott MGH
Oncogene; 2021 Mar; 40(12):2243-2257. PubMed ID: 33649538
[TBL] [Abstract][Full Text] [Related]
15. The SUMO-specific protease SENP1 deSUMOylates p53 and regulates its activity.
Chauhan KM; Chen Y; Chen Y; Liu AT; Sun XX; Dai MS
J Cell Biochem; 2021 Feb; 122(2):189-197. PubMed ID: 32786121
[TBL] [Abstract][Full Text] [Related]
16. SENP2 negatively regulates cellular antiviral response by deSUMOylating IRF3 and conditioning it for ubiquitination and degradation.
Ran Y; Liu TT; Zhou Q; Li S; Mao AP; Li Y; Liu LJ; Cheng JK; Shu HB
J Mol Cell Biol; 2011 Oct; 3(5):283-92. PubMed ID: 22028379
[TBL] [Abstract][Full Text] [Related]
17. DNA damage-induced heterogeneous nuclear ribonucleoprotein K sumoylation regulates p53 transcriptional activation.
Pelisch F; Pozzi B; Risso G; Muñoz MJ; Srebrow A
J Biol Chem; 2012 Aug; 287(36):30789-99. PubMed ID: 22825850
[TBL] [Abstract][Full Text] [Related]
18. Nucleocytoplasmic shuttling modulates activity and ubiquitination-dependent turnover of SUMO-specific protease 2.
Itahana Y; Yeh ET; Zhang Y
Mol Cell Biol; 2006 Jun; 26(12):4675-89. PubMed ID: 16738331
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of SENP2-mediated Akt deSUMOylation promotes cardiac regeneration via activating Akt pathway.
Chen Y; Xu T; Li M; Li C; Ma Y; Chen G; Sun Y; Zheng H; Wu G; Liao W; Liao Y; Chen Y; Bin J
Clin Sci (Lond); 2021 Mar; 135(6):811-828. PubMed ID: 33687053
[TBL] [Abstract][Full Text] [Related]
20. The Epstein-Barr Virus Oncoprotein, LMP1, Regulates the Function of SENP2, a SUMO-protease.
Selby TL; Biel N; Varn M; Patel S; Patel A; Hilding L; Ray A; Ross T; Cramblet WT; Moss CR; Lowrey AJ; Bentz GL
Sci Rep; 2019 Jul; 9(1):9523. PubMed ID: 31266997
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
